
When China Fits a Global Clinical Development Strategy (Sponsored)
China can play several roles in a global clinical development program, from supporting a capital-efficient proof-of-concept study to contributing evidence within a multiregional clinical trial. In this sponsored episode of The Top Line, Caidya Chief Operating Officer Mike Clay and Vice President of Business Development Jinye Shen join Fierce Life Sciences’ Will Herth to discuss how sponsors can decide when and how to include China.
The conversation examines China-only, multiregional and sequenced development approaches, and how the intended use of China-generated evidence should shape…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.